ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,397, issued on May 12, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).
"Biomarkers associated with anti-IL-36R antibody treatment in generalized pustular psoriasis" was invented by Patrick Baum (Warthausen, Germany), Ahmed Karim Farag (Biberach, Germany) and Sudha Visvanathan (Hartsdale, N.Y.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This invention generally relates to biomarkers associated with anti-IL-36R antibody treatment in generalized pustular psoriasis (GPP). The invention also relates to methods of using the biomarkers disclosed."
The patent was filed on March 10, 2022, under Application No. 17/691...